SOUTH SAN FRANCISCO, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (NASDAQ:AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, today announced management will present at the following investor conferences this month:
- Jefferies London Healthcare Conference: Fireside chat on Wednesday, November 15 at 5:00 p.m. GMT
- Evercore ISI HealthCONx Conference: Fireside chat on Wednesday, November 29 at 7:30 a.m. ET
Live webcasts of the Company presentations will be available through the investor relations section of ...